Inotersen Sodium and Insulin glargine
Determining the interaction of Inotersen Sodium and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Sodium-Insulin Glargine (U-100) Cartridge Systems and Pens
- Inotersen Sodium-Insulin Glargine (U-100) Vials
- Inotersen Sodium-Insulin Glargine (U-300) Pens
- Inotersen Sodium-Insulin glargine and lixisenatide
- Inotersen Sodium-Insulin glargine and lixisenatide Subcutaneous
- Inotersen Sodium-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Inotersen Subcutaneous
- Insulin glargine-Inotuzumab ozogamicin
- Insulin glargine-Inotuzumab ozogamicin Intravenous
- Insulin glargine-Inova
- Insulin glargine-Inova 4/1 topical
- Insulin glargine-Inova 8/2 topical